Nextremity Solutions Gains FDA 510(k) for Subtalar Joint Fusion

Nextremity Solutions received FDA 510(k) clearance to market its upcoming InCore® Subtalar System.

Expanding on the InCore brand, preceded by the InCore Lapidus System and InCore TMT System, InCore Subtalar provides surgeons with a three-part intraosseous fixation option for subtalar joint arthrodesis.

“This is the fourth 510(k) clearance that...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us